Biomarkers of sepsis and their potential value in diagnosis, prognosis and treatment

Expert Review of Clinical Immunology

Volumn 10, Issue 10, 2014, Pages 1349-1356

  Sandquist, Mary ^a,b   Wong, Hector R ^a,b  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

biomarker; cfDNA; combination biomarkers; companion diagnostics; IL 27; miRNA; neutrophil CD64; presepsin; sepsis; suPAR; TREM 1

Indexed keywords

BIOLOGICAL MARKER; CD64 ANTIGEN; CELL FREE DNA; CHEMOKINE; CYTOKINE; DNA FRAGMENT; ENDOTOXIN; GLYCOPROTEIN; IMMUNOGLOBULIN; INTERLEUKIN 27; MICRORNA; PRESEPSIN; TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 1; UNCLASSIFIED DRUG; UROKINASE RECEPTOR;

BACTERIAL INFECTION; CRITICALLY ILL PATIENT; CYTOKINE PRODUCTION; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; INTENSIVE CARE UNIT; PREDICTIVE VALUE; PROGNOSIS; REVIEW; SEPSIS; SEPTIC SHOCK; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TREATMENT RESPONSE;

BIOMARKERS; HUMANS; PROGNOSIS; SEPSIS;

EID: 84907271131     PISSN: 1744666X     EISSN: 17448409     Source Type: Journal    
DOI: 10.1586/1744666X.2014.949675     Document Type: Review

References (54)

1. Biomarkers Definitions Working Group. Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework. Clin Pharmacol Ther 2001; 69(3):89-95
2. Kaplan JM, Wong HR. Biomarker discovery and development in pediatric critical care medicine. Pediatr Crit Care Med 2011;12(2):165-73
3. Marshall JC, Reinhart K; International Sepsis F. Biomarkers of sepsis. Crit Care Med 2009;37(7):2290-8
4. Puntmann VO. How-To guide on biomarkers: Biomarker definitions, validation and applications with examples from cardiovascular disease. Postgrad Med J 2009;85(1008):538-45
5. Dupuy AM, Philippart F, Pean Y, et al. Role of biomarkers in the management of antibiotic therapy: An expert panel review: I-currently available biomarkers for clinical use in acute infections. Ann Intensive Care 2013;3(1):22
6. Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference. Crit Care Med 2003;31(4):1250-6
7. Vincent JL, Rello J, Marshall J, et al. International study of the prevalence and outcomes of infection in intensive care units. JAMA 2009;302(21):2323-9
8. Kumar A, Roberts D, Wood KE, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006;34(6):1589-96
9. Pierrakos C, Vincent JL. Sepsis biomarkers: A review. Crit Care 2010;14(1):R15
10. Jiyong J, Tiancha H, Wei C, Huahao S. Diagnostic value of the soluble triggering receptor expressed on myeloid cells-1 in bacterial infection: A meta-Analysis. Intensive Care Med 2009;35(4):587-95
11. Wojno ED, Hunter CA. New directions in the basic and translational biology of interleukin-27. Trends Immunol 2012; 33(2):91-7
12. Bosmann M, Ward PA. Modulation of inflammation by interleukin-27. J Leukoc Biol 2013;94(6):1159-65
13. Pflanz S, Timans JC, Cheung J, et al. IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4(+) T cells. Immunity 2002; 16(6):779-90
14. Villarino AV, Larkin J 3rd, Saris CJ, et al. Positive and negative regulation of the IL-27 receptor during lymphoid cell activation. J Immunol 2005;174(12): 7684-91
15. Wirtz S, Tubbe I, Galle PR, et al. Protection from lethal septic peritonitis by neutralizing the biological function of interleukin 27. J Exp Med 2006;203(8): 1875-81
16. Wong HR, Cvijanovich NZ, Hall M, et al. Interleukin-27 is a novel candidate diagnostic biomarker for bacterial infection in critically ill children. Crit Care 2012; 16(5):R213
17. Wong HR, Lindsell CJ, Lahni P, et al. Interleukin 27 as a sepsis diagnostic biomarker in critically ill adults. Shock 2013;40(5):382-6
18. Wong HR, Liu KD, Kangelaris KN, et al. Performance of interleukin-27 as a sepsis diagnostic biomarker in critically ill adults. J Crit Care 2014. [Epub ahead of print]
19. Krumbiegel D, Anthogalidis-Voss C, Markus H, et al. Enhanced expression of IL-27 mRNA in human newborns. Pediatr Allergy Immuniol 2008;19(6):513-16
20. Eugen-Olsen J, Gustafson P, Sidenius N, et al. The serum level of soluble urokinase receptor is elevated in tuberculosis patients and predicts mortality during treatment: A community study from Guinea-Bissau. Int J Tuberc Lung Dis 2002;6(8):686-92
21. Ostergaard C, Benfield T, Lundgren JD, Eugen-Olsen J. Soluble urokinase receptor is elevated in cerebrospinal fluid from patients with purulent meningitis and is associated with fatal outcome. Scand J Infect Dis 2004;36(1):14-19
22. Donadello K, Scolletta S, Taccone FS, et al. Soluble urokinase-Type plasminogen activator receptor as a prognostic biomarker in critically ill patients. J Crit Care 2014; 29(1):144-9
23. Wittenhagen P, Kronborg G, Weis N, et al. The plasma level of soluble urokinase receptor is elevated in patients with Streptococcus pneumoniae bacteraemia and predicts mortality. Clin Microbiol Infect 2004;10(5):409-15
24. Molkanen T, Ruotsalainen E, Thorball CW, Jarvinen A. Elevated soluble urokinase plasminogen activator receptor (suPAR) predicts mortality in Staphylococcus aureus bacteremia. Eur J Clin Microbiol Infect Dis 2011;30(11):1417-24
25. Huttunen R, Syrjanen J, Vuento R, et al. Plasma level of soluble urokinase-Type plasminogen activator receptor as a predictor of disease severity and case fatality in patients with bacteraemia: A prospective cohort study. J Intern Med 2011;270(1): 32-40
26. Hoffmann JJ. Neutrophil CD64 as a sepsis biomarker. Biochem Med 2011;21(3): 282-90
27. Hoffmann JJ. Neutrophil CD64: A diagnostic marker for infection and sepsis. Clin Chem Lab Med 2009;47(8):903-16
28. Cid J, Aguinaco R, Sanchez R, et al. Neutrophil CD64 expression as marker of bacterial infection: A systematic review and meta-Analysis. J Infect 2010;60(5):313-19
29. Livaditi O, Kotanidou A, Psarra A, et al. Neutrophil CD64 expression and serum IL-8: Sensitive early markers of severity and outcome in sepsis. Cytokine 2006;36(5-6): 283-90
30. Ulla M, Pizzolato E, Lucchiari M, et al. Diagnostic and prognostic value of presepsin in the management of sepsis in the emergency department: A multicenter prospective study. Crit Care 2013;17(4): R168
31. Romualdo LG, Torrella PE, Gonzalez MV, et al. Diagnostic accuracy of presepsin (soluble CD14 subtype) for prediction of bacteremia in patients with systemic inflammatory response syndrome in the Emergency Department. Clin Biochem 2014;47(7-8):505-8
32. Masson S, Caironi P, Spanuth E, et al. Presepsin (soluble CD14 subtype) and procalcitonin levels for mortality prediction in sepsis: Data from the Albumin Italian Outcome Sepsis trial. Crit Care 2014;18(1):R6
33. Endo S, Suzuki Y, Takahashi G, et al. Presepsin as a powerful monitoring tool for the prognosis and treatment of sepsis: A multicenter prospective study. J Infect Chemother 2014;20(1):30-4
34. Rhodes A, Wort SJ, Thomas H, et al. Plasma DNA concentration as a predictor of mortality and sepsis in critically ill patients. Crit Care 2006;10(2):R60
35. Saukkonen K, Lakkisto P, Pettila V, et al. Cell-free plasma DNA as a predictor of outcome in severe sepsis and septic shock. Clin Chem 2008;54(6):1000-7
36. Dwivedi DJ, Toltl LJ, Swystun LL, et al. Prognostic utility and characterization of cell-free DNA in patients with severe sepsis. Crit Care 2012;16(4):R151
37. Forsblom E, Aittoniemi J, Ruotsalainen E, et al. High cell-free DNA predicts fatal outcome among Staphylococcus aureus bacteraemia patients with intensive care unit treatment. PLoS One 2014;9(2):e87741
38. Bartel DP. MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 2004;116(2):281-97
39. Wang HJ, Wang BZ, Zhang PJ, et al. Identification of four novel serum protein biomarkers in sepsis patients encoded by target genes of sepsis-related miRNAs. Clin Sci 2014;126(12):857-67
40. Tacke F, Roderburg C, Benz F, et al. Levels of Circulating miR-133a Are Elevated in Sepsis and Predict Mortality in Critically Ill Patients. Crit Care Med 2014;42(5): 1096-104
41. Wang JF, Yu ML, Yu G, et al. Serum miR-146a and miR-223 as potential new biomarkers for sepsis. Biochem Biophys Res Commun 2010;394(1):184-8
42. Gibot S, Bene MC, Noel R, et al. Combination biomarkers to diagnose sepsis in the critically ill patient. Am J Respir Crit Care Med 2012;186(1):65-71
43. Wong HR, Salisbury S, Xiao Q, et al. The pediatric sepsis biomarker risk model. Crit Care 2012;16(5):R174
44. Wong HR, Weiss SL, Giuliano JS Jr, et al. Testing the prognostic accuracy of the updated pediatric sepsis biomarker risk model. PLoS One 2014;9(1):e86242
45. Wong HR, Weiss SL, Giuliano JS Jr, et al. The temporal version of the pediatric sepsis biomarker risk model. PLoS One 2014;9(3): E92121
46. Wong HR, Lindsell CJ, Pettila V, et al. A multibiomarker-based outcome risk stratification model for adult septic shock. Crit Care Med 2014;42(4):781-9
47. Alder MN, Lindsell CJ, Wong HR. The pediatric sepsis biomarker risk model: Potential implications for sepsis therapy and biology. Expert Rev Anti Infect Ther 2014; 12(7):809-16
48. Olsen D, Jorgensen JT. Companion diagnostics for targeted cancer drugs-clinical and regulatory aspects. Front Oncol 2014;4:105
49. Meisel C, Schefold JC, Pschowski R, et al. Granulocyte-macrophage colony-stimulating factor to reverse sepsis-Associated immunosuppression: A double-blind, randomized, placebo-controlled multicenter trial. Am J Respir Crit Care Med 2009; 180(7):640-8
50. Safety and efficacy of polymyxin b hemoperfusion (PMX) for septic shock. Available from: Www.clinicaltrials.gov/ct2/ results?term=NCT01046669&Search=Search
51. Bossuyt PM, Reitsma JB, Bruns DE, et al. Towards complete and accurate reporting of studies of diagnostic accuracy: The STARD Initiative. Ann Intern Med 2003;138(1):40-4
52. Rifai N, Gillette MA, Carr SA. Protein biomarker discovery and validation: The long and uncertain path to clinical utility. Nat Biotechnol 2006;24(8):971-83
53. Maslove DM, Wong HR. Gene expression profiling in sepsis: Timing, tissue, and translational considerations. Trends Mol Med 2014;20(4):204-13
54. Mickiewicz B, Vogel HJ, Wong HR, Winston BW. Metabolomics as a novel approach for early diagnosis of pediatric septic shock and its mortality. Am J Respir Crit Care Med 2013;187(9):967-76